Cite
HARVARD Citation
Kaufman, J. et al. (2013). A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma. Transfusion. 53 (1), pp. 76-84. [Online].